Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials

Autor: Kyriakoulis, Kg, Dimakakos, E, Kyriakoulis, Ig, Catalano, M, Spyropoulos, Ac, Schulman, S, Douketis, J, Falanga, A, Maraveyas, A, Olinic, Dm, Belch, J, Gerotziafas, G, Syrigos, K, Kollias, A, Darko Antic, Aleš, Blinc, Francesco, Boccardo, Marianne, Brodmann, Varusca, Brusegan, Alexandra, Canedo, Denisa, Čelovská, Benilde, Cosmi, DE MARCHI, Sergio, Gabriel, Dimitrov, Katalin, Farkas, Anders, Gottsäter, Christian, Heiss, Oguz, Karahan, Endre, Kolossváry, Matija, Kozak, Abraham, Kroon, Gianfranco, Lessiani, Aaron, Liew, George, Marakomichelakis, Peter, Marschang, Lucia, Mazzolai, Nikolaos-Georgios, Papageorgiou, Sergio, Pillon, Pavel, Poredos, Dusan, Suput, Marc, Righini, Gerit-Holger, Schernthaner, Aleksander, Sieroń, Jonas, Spaak, Muriel, Sprynger, Agata, Stanek, Daniel, Staub, Igor, Stojkovski, Adriana, Visonà, Dragan, Vasic, Jean-Claude, Wautrecht, Andrea, Willfort-Ehringer, Isabelle, Durand-Zaleski, Pecsvarady, Zsolt

Publikováno v: Journal of clinical medicine. 11(20)

Coronavirus disease 2019 (COVID-19) has been shown to be strongly associated with increased risk for venous thromboembolism events (VTE) mainly in the inpatient but also in the outpatient setting. Pharmacologic thromboprophylaxis has been shown to of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9223cc2250471e1f5411cb9f79f16a2
https://pubmed.ncbi.nlm.nih.gov/36294316

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow

Autor: Bikdeli, B, Madhavan, MV, Jimenez, D, Chuich, T, Dreyfus, I, Driggin, E, Der Nigoghossian, C, Ageno, W, Madjid, M, Guo, YT, Tang, LV, Hu, Y, Giri, J, Cushman, M, Quere, I, Dimakakos, EP, Gibson, CM, Lippi, G, Favaloro, EJ, Fareed, J, Caprini, JA, Tafur, AJ, Burton, JR, Francese, DP, Wang, EY, Falanga, A, McLintock, C, Hunt, BJ, Spyropoulos, AC, Barnes, GD, Eikelboom, JW, Weinberg, I, Schulman, S, Carrier, M, Piazza, G, Beckman, JA, Steg, G, Stone, GW, Rosenkranz, S, Goldhaber, SZ, Parikh, SA, Monreal, M, Krumholz, HM, Konstantinides, SV, Weitz, JI, Lip, GYH

Publikováno v: Journal Of The American College Of Cardiology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic disease, both in the venous and arterial circulations, because of exces

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::542917fe0cc3942450036fa9f6218882
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4267

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.